Skip to content
healthcare.dev

Divalproex Sodium

NDC 71610-031, Divalproex Sodium, tablet, delayed release, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-031
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078182
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-031 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIVALPROEX SODIUM250 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]

Package NDCNDC-11Package
71610-031-607161000316090 TABLET, DELAYED RELEASE in 1 BOTTLE (71610-031-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b74adc5e-e92d-46a7-afdc-a6464a440bde

Use it

Look up 71610-031 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-031 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-031. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.